STOCK TITAN

Bayview Acquisition (BAYA) extends Merger Outside Closing Date to Dec 19, 2026

Filing Impact
(High)
Filing Sentiment
(Neutral)
Form Type
425

Rhea-AI Filing Summary

Bayview Acquisition Corp entered into Amendment No. 4 to its previously disclosed Merger Agreement, extending the Outside Closing Date. The parties agreed to extend the Outside Closing Date to December 19, 2026. The filing references prior amendments, including the original Merger Agreement dated June 7, 2024, Amendment No. 1 dated June 26, 2024, Amendment No. 2 dated May 14, 2025, and Amendment No. 3 dated January 21, 2026. A copy of Amendment No. 4 is filed as Exhibit 2.1 and is incorporated by reference.

Positive

  • None.

Negative

  • None.

Insights

Amendment extends closing deadline to December 19, 2026.

The filing records Amendment No. 4 to the Merger Agreement, which moves the contractual Outside Closing Date to December 19, 2026. The amendment is appended as Exhibit 2.1 and the summary is qualified by reference to that exhibit.

Key dependencies include the unmodified contractual provisions inside the Merger Agreement and any remaining closing conditions; timing and consummation remain conditioned on those terms. Subsequent filings or the exhibit will show whether additional changes or waivers accompany this extension.

Amendment No. 4 action Outside Closing Date extended to December 19, 2026 Amendment No. 4 to Merger Agreement
Prior Outside Closing Date June 15, 2026 Outside Closing Date set by Amendment No. 3 dated January 21, 2026
Original Merger Agreement date June 7, 2024 Agreement and Plan of Merger entered into among the parties
Amendment No. 1 date June 26, 2024 Revised earnout milestones per filing
Amendment No. 2 date May 14, 2025 Realigned transaction sequence per filing
Amendment No. 3 date January 21, 2026 Extended Outside Closing Date to June 15, 2026
Outside Closing Date regulatory
"extend the Outside Closing Date to December 19, 2026"
Merger Agreement financial
"entered into an Agreement and Plan of Merger (the “Merger Agreement”)"
A merger agreement is a binding contract that lays out the exact terms for two companies to combine, including the price, what each side will deliver, and the conditions that must be met before the deal is completed. Investors care because it sets the timetable, payouts and risks — like a blueprint or prenup that shows whether the deal is likely to close, how ownership will change, and what could cancel or alter the payout they expect.
earnout milestones financial
"agreed to revise the earnout milestones to reflect new consolidated revenue metrics"
Exhibit 2.1 regulatory
"a copy of the Fourth Amendment is filed as Exhibit 2.1"

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

FORM 8-K

 

 

 

current report
pursuant to section 13 or 15(D)
of the securities exchange act of 1934

 

Date of Report (Date of earliest event reported): May 19, 2026

 

 

 

Bayview Acquisition Corp

(Exact name of registrant as specified in its charter)

 

 

 

Cayman Islands   001-41890   N/A 00-0000000
(State or other jurisdiction
of incorporation)
  (Commission
File Number)
  (I.R.S. Employer
Identification Number)

 

420 Lexington Ave, Suite 2446

New York, NY 10170

(Address of principal executive offices, including zip code)

 

Registrant’s telephone number, including area code (347) 627-0058

 

Not Applicable
(Former name or former address, if changed since last report)

 

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
  
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
  
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
  
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Securities Exchange Act of 1934:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Units, each consisting of one ordinary share and one right   BAYAU   The Nasdaq Stock Market LLC
Ordinary Shares, par value $0.0001 per share   BAYA   The Nasdaq Stock Market LLC
Rights, each right entitling the holder thereof to one-tenth of one ordinary share   BAYAR   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act ☐

 

 

 

 

 

 

Item 1.01 Entry into a Material Definitive Agreement.

 

Amendment to Merger Agreement

 

As previously disclosed, on June 7, 2024, Bayview Acquisition Corp, a Cayman Islands exempted company (the “Company”) entered into an Agreement and Plan of Merger (the “Merger Agreement”) by and among the Company, Oabay Holding Company, a Cayman Islands exempted company limited by shares (“PubCo”), Oabay Inc., a Cayman Islands exempted company limited by shares, Bayview Merger Sub 1 Limited, a Cayman Islands exempted company limited by shares and a wholly-owned subsidiary of PubCo, Bayview Merger Sub 2, a Cayman Islands exempted company limited by shares and a wholly-owned subsidiary of PubCo, Oabay Merger Sub Limited, a Cayman Islands exempted company limited by shares and a wholly-owned subsidiary of PubCo, BLAFC Limited, a business company limited by shares in the British Virgin Islands, Bayview Holding LP, a Delaware limited partnership, and Peace Investment Holdings Limited, a Delaware limited partnership.

 

On June 26, 2024, the parties to the Merger Agreement entered into Amendment No. 1 to the Merger Agreement pursuant to which, among other things, the parties agreed to revise the earnout milestones to reflect new consolidated revenue metrics. On May 14, 2025, the parties to the Merger Agreement entered into Amendment No. 2 to the Merger Agreement pursuant to which the parties agreed to realign the sequence of the transactions contemplated by the Merger Agreement. On January 21, 2026, the parties to the Merger Agreement entered into Amendment No. 3 to the Merger Agreement, pursuant to which the parties agreed to extend the Outside Closing Date (as defined in the Merger Agreement) to June 15, 2026.

 

On May 19, 2026, the parties to the Merger Agreement entered into Amendment No. 4 to the Merger Agreement, pursuant to which the parties agreed to extend the Outside Closing Date to December 19, 2026.

 

The foregoing summary of the Fourth Amendment does not purport to be complete and is qualified in its entirety by reference to the Fourth Amendment, a copy of which is filed as Exhibit 2.1 and is incorporated by reference herein.

 

Forward-Looking Statements

 

This Current Report on Form 8-K may include “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Certain of these forward-looking statements can be identified by the use of words such as “believes,” “expects,” “intends,” “plans,” “estimates,” “assumes,” “may,” “should,” “will,” “seeks,” or other similar expressions. Such statements are subject to certain risks and uncertainties that may cause the Company’s actual results to differ from the expectations expressed in the forward-looking statements. There can be no assurance that the Company will achieve such expectations. The forward-looking statements contained in this report speak only as of the date of this report and the Company undertakes no obligation to publicly update any forward-looking statements to reflect changes in information, events or circumstances after the date of this report, unless required by law.

 

2/4

 

 

Item 9.01. Financial Statements and Exhibits

 

(d) Exhibits.

 

The Exhibit Index is incorporated by reference herein.

 

EXHIBIT INDEX

 

Exhibit No.   Description
2.1   Amendment No. 4 to Merger Agreement, dated May 19, 2026.
104   Cover Page Interactive Data File (embedded with the Inline XBRL document).

 

3/4

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  BAYVIEW ACQUISITION CORP
     
Date: May 19, 2026 By: /s/ Xin Wang
  Name: Xin Wang
  Title: Chief Executive Officer

 

4/4

 

FAQ

What did Bayview Acquisition Corp (BAYA) disclose in this 8-K?

It disclosed Amendment No. 4 to the Merger Agreement extending the Outside Closing Date. The amendment moves the Outside Closing Date to December 19, 2026 and the amendment is filed as Exhibit 2.1 and incorporated by reference.

What is the new Outside Closing Date for the Merger Agreement?

The new Outside Closing Date is December 19, 2026. This date replaces the prior Outside Closing Date that had been extended previously to June 15, 2026 under Amendment No. 3.

What prior amendments to the Merger Agreement does the filing reference?

The filing references Amendment No. 1, No. 2 and No. 3. It cites Amendment No. 1 dated June 26, 2024, Amendment No. 2 dated May 14, 2025, and Amendment No. 3 dated January 21, 2026.

Where can I find the full text of Amendment No. 4?

The full text of Amendment No. 4 is filed as Exhibit 2.1 to this Form 8-K. The summary in the 8-K is qualified in its entirety by reference to that exhibit, which contains the detailed amendment language and any conditions.

Does the 8-K state reasons for the extension to December 19, 2026?

The 8-K does not state reasons beyond documenting the contractual extension. The report summarizes the extension and incorporates the amendment as Exhibit 2.1; any explanatory detail would appear in that exhibit or future disclosures.